July 16, 2026 Contact: (916) 210-6000, agpressoffice@doj.ca.gov If you bought certain generic prescription drugs in the United States between May 1, 2009, and December 31, 2019, you could be eligible for compensation OAKLAND — California Attorney General Rob Bonta joined a coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark to resolve allegations that the generic drug manufacturer engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs. As part of the settlement agreement, Glenmark agrees to cooperate in the ongoing multistate litigations against 33 other corporate Defendants and 25 individual executives. The company has further agreed to a series of internal reforms to ensure fair competition and compliance with antitrust laws. “Artificially inflating drug prices and blocking competition hurts consumers and the marketplace — full stop,” said Attorney General Bonta. “I'm pleased to resolve our claims against Glenmark with this settlement and stay focused on our ongoing litigation against others who have attempted to do the same.” If you purchased a generic prescription drug manufactured by either Glenmark, Lannett, Bausch, Apotex, or Heritage between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit this website. The Glenmark settlement follows settlements with Lannett, Bausch, Apotex, and Heritage totaling $66.95 million. This latest settlement comes as the States prepare for the first trial to be held in Hartford, Connecticut. The California Attorney General’s Office has been part of a coalition of nearly all states and territories pursuing a series of antitrust cases since 2016. The first complaint included Heritage and 17 other corporate Defendants, two individual Defendants, and 15 generic drugs. Two former executives from Heritage Pharmaceuticals, Jeffery Glazer and Jason Malek, have since entered into settlement agreements and are cooperating. The second complaint was filed in 2019 against Teva Pharmaceuticals and 21 of the nation’s largest generic drug manufacturers. The complaint names 16 individual senior executive Defendants. The third complaint, to be tried first, focuses on 80 topical generic drugs that account for billions of dollars in sales in the United States and names 26 corporate Defendants and 10 individual Defendants. Seven additional pharmaceutical executives have been cooperating to support the States’ claims
Settlement payout
Amount varies
Final amount depends on how many valid claims are filed
Step-by-step instructions for this one aren't available yet. Start the claim and we'll take you to the official source to file it.
Start claimPay it forward
Most people never find out they're owed money. Sharing takes 10 seconds and could put real money in a friend's pocket.
Individuals who lived at Skyline Apartments in Syracuse, New York for at least one month between 2017 and 2023 may qualify to claim a cash settlement payment from an $800,000 settlement fund
$25,000
estimated
Did your child use Google Play apps before age 13, any time since April 2015? Google settled claims it collected children's personal data through its AdMob ad network for $8.25 million. No receipts or records needed, a parent fills out and signs the claim. Deadline: September 14, 2026
$25,000
estimated
Consumers who leased a vehicle and had their excess wear and tear waiver claim denied may be eligible to claim a settlement payment from a $450,000 class action settlement
$25,000
estimated
Used the Flo period and ovulation tracker app between November 2016 and February 2019 and entered period or pregnancy info? Flo, Google, and Flurry settled privacy claims for $59.5 million. You just attest that you used the app, no receipts or screenshots. California users get a double share. Deadline: October 15, 2026
$25,000
estimated